Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients

被引:10
|
作者
Kato, Tomoko [1 ]
Konishi, Yoshihiro [2 ]
Shimohama, Shun [3 ]
Beach, Thomas G. [4 ]
Akatsu, Hiroyasu [5 ]
Tooyama, Ikuo [1 ]
机构
[1] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan
[2] Nishi Tottori Natl Hosp, Dept Clin Res, Tottori 6890202, Japan
[3] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan
[4] Banner Sun Hlth Res Inst, Sun City, AZ 85372 USA
[5] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan
关键词
Alzheimer's disease; alpha; 1-chimaerin; Rac1; In situ hybridization; Real-time PCR; NEUROFIBRILLARY TANGLES; PYRAMIDAL NEURONS; NUCLEUS BASALIS; SPINE DENSITY; N-CHIMAERIN; KINASE; CDK5; HYPOTHESIS; INCREASES; PATHOLOGY;
D O I
10.1016/j.neulet.2015.02.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha1-chimaerin is a GTPase-activating protein (GAP) for Rac1, a member of the Rho small GTPase family, whose action leads to the inactivation of Rac1. Rac1 activity is upregulated in Alzheimer's disease, but little is known about the role of alpha 1-chimaerin. In this study, we investigated the expression and localization of alpha 1-chimaerin mRNA in postmortem human brains from patients with Alzheimer's disease and control subjects. In situ hybridization studies demonstrated that alpha 1 -chimaerin was expressed by neurons in the neo-cortex of the temporal lobe and the hippocampus of both controls and Alzheimer's disease cases, with the signal intensity dramatically decreased in patients with Alzheimer's disease. Realtime PCR analysis confirmed a significant reduction of alpha 1-chimaerin mRNA expression in the temporal cortex of Alzheimer's disease cases. In contrast, alpha 2-chimaerin mRNA levels showed no significant difference between the groups. The present study showed reduced alpha 1-chimaerin expression in the brain of Alzheimer's disease cases, suggesting a role in the upregulation of Rac1 activity during the disease process. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [21] Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson's disease, dementia with Lewy bodies and Alzheimer's disease
    Frykman, S.
    Oosterhof, M.
    Ahmed, M. S.
    Howlet, D.
    Hortobagyi, T.
    Francis, P.
    Arsland, D.
    MOVEMENT DISORDERS, 2016, 31 : S268 - S268
  • [22] α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease
    Quinn, Joseph G.
    Coulson, David T. R.
    Brockbank, Simon
    Beyer, Nancy
    Ravid, Rivka
    Hellemans, Jan
    Irvine, G. Brent
    Johnston, Janet A.
    BRAIN RESEARCH, 2012, 1459 : 71 - 80
  • [23] Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
    Padmanabhan, Jaya
    Levy, Monique
    Dickson, Dennis W.
    Potter, Huntington
    BRAIN, 2006, 129 : 3020 - 3034
  • [24] Association of Estrogen Receptor 1 PvuII and XbaI Polymorphisms and Peripheral Estrogen Receptor 1 mRNA Levels with Alzheimer's Disease in Turkish Patients
    Gueven, Gamze
    Koeseoglu-Bueyuekkaya, Pinar
    Kilic, Melisa
    Uzun, Damla
    Cavus, Betuel
    Gueclue-Geyik, Filiz
    Lohmann, Ebba
    Samanci, Bedia
    Guervit, Hakan
    Hanagasi, Hasmet
    Bilgic, Basar
    TURKISH JOURNAL OF NEUROLOGY, 2023, 29 (03) : 195 - 203
  • [25] Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients
    Vogelsang, Petra
    Giil, Lasse Melvaer
    Lund, Anders
    Vedeler, Christian A.
    Parkar, Anagha P.
    Nordrehaug, Jan Erik
    Kristoffersen, Einar K.
    BRAIN RESEARCH, 2018, 1678 : 304 - 309
  • [26] A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
    Deben, Debbie S.
    Creemers, Rob H.
    van Adrichem, Arjan J.
    Drent, Roosmarie
    Merry, Audrey H. H.
    Leers, Mathie P. G.
    van Bodegraven, Adriaan A.
    Wong, Dennis R.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Reduced expression of SIRT1 and SOD-1 and the correlation between these levels in various regions of the brains of patients with Alzheimer's disease
    Cao, Kun
    Dong, Yang-Ting
    Xiang, Jie
    Xu, Yi
    Hong, Wei
    Song, Hui
    Guan, Zhi-Zhong
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (12) : 1090 - 1099
  • [28] A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
    Debbie S. Deben
    Rob H. Creemers
    Arjan J. van Adrichem
    Roosmarie Drent
    Audrey H. H. Merry
    Mathie P. G. Leers
    Adriaan A. van Bodegraven
    Dennis R. Wong
    Scientific Reports, 12
  • [29] Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients
    Jessyka Maria de França Bram
    Leda Leme Talib
    Helena Passarelli Giroud Joaquim
    Tamires Alves Sarno
    Wagner Farid Gattaz
    Orestes Vicente Forlenza
    European Archives of Psychiatry and Clinical Neuroscience, 2019, 269 : 963 - 972
  • [30] Patients with mild cognitive impairment and a reduced CSF Aβ1-42 protein progress rapidly to Alzheimer's disease
    Monge-Argiles, J. A.
    Sanchez-Paya, J.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Rodriguez Borja, E.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    NEUROLOGIA, 2012, 27 (01): : 28 - 33